|
Press Releases |
|
 |
|
Tuesday, June 7, 2022 |
|
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022 |
Hua Medicine (the "Company", stock code: 2552.HK) today announces that several clinical findings were presented on its global first-in-class drug, glucokinase activator (GKA) dorzagliatin, at the 82nd American Diabetes Association (ADA) Annual Scientific Sessions. more info >> |
|
Friday, May 13, 2022 |
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine |
Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin more info >> |
|
Thursday, March 17, 2022 |
|
Hua Medicine Announces 2021 Annual Results |
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period"). The Reporting Period witnessed significant milestones in the commercialization process of dorzagliatin. more info >> |
|
Sunday, September 26, 2021 |
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
Wednesday, September 15, 2021 |
|
Hua and Sinopharm Announced Supply Chain Strategic Cooperation |
On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099). more info >> |
|
Thursday, August 19, 2021 |
|
Hua Medicine Announces 2021 Interim Results |
Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the consolidated results of the Company and its subsidiaries for the six months ended June 30, 2021 (the "Reporting Period"). more info >> |
|
Friday, April 23, 2021 |
|
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally |
Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). more info >> |
|
Friday, March 19, 2021 |
|
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission |
Hua Medicine (2552.HK), today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2020 (the "Reporting Period"). more info >> |
|
Friday, December 18, 2020 |
|
Hua Medicine Completes Registration Phase III Trials; Announces 52-Week Result for DAWN (HMM0302), Dorzagliatin's Phase III Combination with Metformin Trial |
Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today announced: more info >> |
|
Wednesday, October 14, 2020 |
|
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin |
Hua Medicine (the "Company", Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder ("MAH") system, the Company has obtained the drug manufacturing permit for dorzagliatin, its investigational first-in-class drug, issued by the Shanghai Municipal Drug Administrative Bureau. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
Jul 4, 2025 18:59 HKT/SGT
|
|
|
DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture
Jul 4, 2025 16:20 JST
|
|
|
MHIET Launches 450kW Gas Cogeneration System Capable of Hydrogen Co-Firing
Jul 4, 2025 15:13 JST
|
|
|
INVEST FAIR Malaysia 2025 Spotlights Investor Trends, Multi-Asset Literacy, and Tech-Driven Platforms
Jul 4, 2025 13:00 HKT/SGT
|
|
|
Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures
Jul 4, 2025 13:25 JST
|
|
|
Fujitsu to implement store monitoring solution for METRO Inc. in Canada, enhancing operational efficiency and policy compliance
Jul 4, 2025 13:19 JST
|
|
|
Chinabank Fully Transitions Into AI-powered Human Capital Management
Jul 3, 2025 20:30 HKT/SGT
|
|
|
UOB Hong Kong becomes first Singapore-based bank to sign MOU with HKTDC
Jul 3, 2025 16:29 HKT/SGT
|
|
|
Fujitsu to develop ETF trading platform based on TSE's CONNEQTOR and provide it to Australian Securities Exchange
Jul 3, 2025 11:14 JST
|
|
|
AI-Powered CX, Operational Efficiency, and Smarter Journeys Redefining Strategies Across UK Enterprises: Customer Experience Live Show UK 2025 Unveils Industry Priorities
Jul 3, 2025 08:59 HKT/SGT
|
|
|
GFEAI 2025 Concludes Successfully: PM Paetongtarn Backs Human-Centric AI, AIGPC Emerges as Regional AI Ethics Hub
Jul 2, 2025 22:20 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Launches in Brazil With Grupo Pasquini
Jul 2, 2025 19:00 HKT/SGT
|
|
|
Baguio Awarded Marine Department Contract for Marine Cleansing in the Eastern Waters of Hong Kong for Approximately HK$150 million
Jul 2, 2025 17:51 HKT/SGT
|
|
|
Ching Lee Holdings (3728.HK) Reports Solid and Resilient Annual Results
Jul 2, 2025 16:58 HKT/SGT
|
|
|
TravelKon Launches Unlimited Europe eSIM Range to Keep Australians Connected over European Summer Getaway
Jul 2, 2025 16:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|